eYantra Ventures Reports Q2 FY27 Results; Consolidated Performance Deferred
Eyantra Ventures Ltd · Financial Result · 13 Nov 2026, 1:25 am
eYantra Ventures Reports Q2 FY27 Results; Consolidated Performance Deferred eYantra Ventures reported standalone revenue from operations of ₹1,938.25 lakhs for Q2 ended 30th Sep'26, up 6.52% YoY from ₹1,819.59 lakhs and 10.00% QoQ from ₹1,762.08 lakhs. Net profit reached ₹57.58 lakhs versus ₹4.35 lakhs in Q2 FY26 and a net loss of ₹8.65 lakhs in Q1 FY27, with basic EPS rising to ₹2.87. Consideration of consolidated results was deferred due to non-receipt of financials from subsidiary Neuro and Spine Associates, keeping the trading window closed.
Original exchange filing (PDF)
More announcements from Eyantra Ventures Ltd
- As attached · 13 Nov 2026
- Outcome of the Board Meeting - unaudited standalone financial results along with limited review report for the quarter and half year ended on September 30, 2026 · 13 Nov 2026
- Eyantra Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve the standalone and consolidated .... · 12 Nov 2026
- Intimation of Scrutinizer''s Report and Voting Result · 02 Oct 2026
- Proceedings of 41st Annual General Meeting of the Company · 01 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vinita Raj Narayanam & PACs · 22 Sept 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Naga Satya Manogana Narayanam & PACs · 22 Sept 2026
- Notice of the 41st Annual General Meeting · 09 Sept 2026
